Table I.

Effects of saikosaponin on the levels of TNF-α, IL-6, MDA and SOD in oxidized low-density lipoprotein-induced human umbilical vein endothelial cells.

Group	TNF-α (pg/ml)	IL-6 (pg/ml)	MDA (nmol/mgprot)	SOD (nmol/mgprot)
Control	82.11±10.21a,c,f	63.89±7.53a,c,e	15.02±1.45a,c,f	170.22±8.73a,c,f
Model	125.28±12.90	108.11±6.51	32.99±2.73	112.09±4.89
10 µM	110.35±10.28b	88.49±1.72	29.02±2.09	120.67±9.62
20 µM	96.12±2.84b	80.65±5.83b	27.84±1.75	133.89±4.91
40 µM	90.23±2.21a,d	71.89±6.66a,c,f	19.04±1.10a,c,f	156.69±1.23a,c

^aP<0.01, vs. Model

^bP<0.05, vs. Model

^cP<0.01. vs. 10 µM

^dP<0.05, vs. 10 µM

^eP<0.01, vs. 20 µM

^fP<0.05, vs. 20 µM. TNF-α, tumor necrosis factor-; IL-6, interleukin-6; MDA, malondialdehyde; SOD, superoxide dismutase.